Drugs Of Abuse Testing Market 2018 2026

Drugs of Abuse Testing Market (Products - Analyzers, Rapid Testing Devices, Consumables; Sample Type - Saliva, Breath, Urine, Blood, Hair and Sweat; Testing Type - Pain Management Testing, Criminal Justice Testing, Workplace Screening; End user - Forensic Laboratories, Diagnostic labs, On-the-spot Testing, Forensic Laboratories) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

  • Rep Id : TMRGL54426
  • Published On : Dec 2018
  • No. of Pages : 196
  • Category : Pharmaceutical

1. Preface
     1.1. Market Definition and Scope
     1.2. Market Segmentation
     1.3. Key Research Objectives
     1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Drugs of Abuse Testing Market

4. Market Overview
     4.1. Introduction
            4.1.1. Product Definition
            4.1.2. Industry Evolution / Developments
     4.2. Market Overview
     4.3. Regulatory Scenario
     4.4. Market Dynamics
            4.4.1. Drivers
            4.4.2. Restraints
            4.4.3. Opportunities
            4.4.4. Trends
     4.5. Market Revenue Projections (US$ Mn)
     4.6. Market Outlook
     4.7. Porter’s Five Forces Analysis 
     4.8. Value Chain Analysis
     4.9. Technology Assessment 
     4.10. Global Demand and Supply Scenario

5. Global Drugs of Abuse Testing Market Analysis and Forecast, by Product Type
     5.1. Introduction 
     5.2. Product Comparison Matrix 
     5.3. Market Revenue Share (%) and Attractiveness Analysis, by Product Type
     5.4. Market Size (US$ Mn) Forecast, by Product Type 
            5.4.1. Analyzers 
                     5.4.1.1. Immunoassay Analyzers
                     5.4.1.2. Chromatographic Devices
                     5.4.1.3. Breath Analyzers
            5.4.2. Rapid Testing Devices
                     5.4.2.1. Urine Testing Devices 
                     5.4.2.2. Oral Fluid Testing Devices
            5.4.3. Consumables
                     5.4.3.1. Fluid Collection Devices
                     5.4.3.2. Others

6. Global Drugs of Abuse Testing Market Analysis and Forecast, by Sample Type
     6.1. Introduction 
     6.2. Market Revenue Share (%) and Attractiveness Analysis, by Sample Type 
     6.3. Market Size (US$ Mn) Forecast, by Sample Type 
            6.3.1. Saliva
            6.3.2. Breath
            6.3.3. Urine
            6.3.4. Blood
            6.3.5. Hair & Sweat

7. Global Drugs of Abuse Testing Market Analysis and Forecast, by Testing Type
     7.1. Introduction 
     7.2. Market Revenue Share (%) and Attractiveness Analysis, by Testing Type 
     7.3. Market Size (US$ Mn) Forecast, by Testing Type 
            7.3.1. Pain Management Testing
            7.3.2. Criminal Justice Testing
            7.3.3. Workplace Screening

8. Global Drugs of Abuse Testing Market Analysis and Forecast, by End-user 
     8.1. Introduction 
     8.2. Market Revenue Share (%) and Attractiveness Analysis, by End-user 
     8.3. Market Size (US$ Mn) Forecast, by End-user 
            8.3.1. Hospitals
            8.3.2. Diagnostics Laboratories
            8.3.3. On-the-spot Testing
            8.3.4. Forensic Laboratories

9. Global Drugs of Abuse Testing Market Analysis and Forecast, by Region 
     9.1. Market Revenue Share (%) and Attractiveness Analysis, by Region 
     9.2. Market Size (US$ Mn) Forecast, by Region 
            9.2.1. North America
            9.2.2. Europe
            9.2.3. Asia Pacific
            9.2.4. Latin America
            9.2.5. Middle East and Africa

10. North America Drugs of Abuse Testing Market Analysis and Forecast
     10.1. Market Overview
            10.1.1. Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016–2026
            10.1.2. Testing Market Attractiveness Analysis, by Country
     10.2. Market Value Share Analysis, by Product Type 
            10.2.1. Analyzers 
                     10.2.1.1. Immunoassay Analyzers
                     10.2.1.2. Chromatographic Devices
                     10.2.1.3. Breath Analyzers
            10.2.2. Rapid Testing Devices
                     10.2.2.1. Urine Testing Devices 
                     10.2.2.2. Oral Fluid Testing Devices
            10.2.3. Consumables
                     10.2.3.1. Fluid Collection Devices
                     10.2.3.2. Others 
     10.3. Market Value Share Analysis, by Sample Type 
            10.3.1. Saliva
            10.3.2. Breath
            10.3.3. Urine
            10.3.4. Blood
            10.3.5. Hair & Sweat
     10.4. Market Value Share Analysis, by Testing Type 
            10.4.1. Pain Management 
            10.4.2. Criminal Justice Testing 
            10.4.3. Workplace Screening
     10.5. Market Value Share Analysis, by End-user 
            10.5.1. Hospitals 
            10.5.2. Diagnostics Laboratories
            10.5.3. On-The-Spot Testing
            10.5.4. Forensic Laboratories
     10.6. Market Value Share Analysis, by Country 
            10.6.1. U.S.
            10.6.2. Canada
     10.7. Market Size (US$ Mn) Forecast
            10.7.1. By Product Type
            10.7.2. By Sample Type
            10.7.3. By Testing Type
            10.7.4. By End-user
            10.7.5. By Country
     10.8. Market Attractiveness Analysis 
            10.8.1. By Product Type
            10.8.2. By Sample Type
            10.8.3. By Testing Type
            10.8.4. By End-user
            10.8.5. By End-user

11. Europe Drugs of Abuse Testing Market Analysis and Forecast
     11.1. Market Overview
            11.1.1. Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016–2026
            11.1.2. Testing Market Attractiveness Analysis, by Country/Sub-region
     11.2. Market Value Share Analysis, by Product Type 
            11.2.1. Analyzers 
                     11.2.1.1. Immunoassay Analyzers
                     11.2.1.2. Chromatographic Devices
                     11.2.1.3. Breath Analyzers
            11.2.2. Rapid Testing Devices
                     11.2.2.1. Urine Testing Devices 
                     11.2.2.2. Oral Fluid Testing Devices
            11.2.3. Consumables
                     11.2.3.1. Fluid Collection Devices
                     11.2.3.2. Others 
     11.3. Market Value Share Analysis, by Sample Type 
            11.3.1. Saliva
            11.3.2. Breath
            11.3.3. Urine
            11.3.4. Blood
            11.3.5. Hair & Sweat
     11.4. Market Value Share Analysis, by Testing Type 
            11.4.1. Pain Management 
            11.4.2. Criminal Justice Testing 
            11.4.3. Workplace Screening
     11.5. Market Value Share Analysis, by End-user 
            11.5.1. Hospitals 
            11.5.2. Diagnostics Laboratories
            11.5.3. On-the-Spot Testing
            11.5.4. Forensic Laboratories
     11.6. Market Value Share Analysis, by Country/Sub-region
            11.6.1. U.K.
            11.6.2. France
            11.6.3. Germany
            11.6.4. Italy
            11.6.5. Spain
            11.6.6. Russia
            11.6.7. Rest of Europe
     11.7. Market Size (US$ Mn) Forecast
            11.7.1. By Product Type
            11.7.2. By Sample Type
            11.7.3. By Testing Type
            11.7.4. By End-user
            11.7.5. By Country/Sub-region
     11.8. Market Attractiveness Analysis 
            11.8.1. By Product Type
            11.8.2. By Sample Type
            11.8.3. By Testing Type
            11.8.4. By End-user

12. Asia Pacific Drugs of Abuse Testing Market Analysis and Forecast
     12.1. Market Overview
            12.1.1. Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016–2026
            12.1.2. Testing Market Attractiveness Analysis, by Country/Sub-region
     12.2. Market Value Share Analysis, by Product Type 
            12.2.1. Analyzers 
                     12.2.1.1. Immunoassay Analyzers
                     12.2.1.2. Chromatographic Devices
                     12.2.1.3. Breath Analyzers
            12.2.2. Rapid Testing Devices
                     12.2.2.1. Urine Testing Devices 
                     12.2.2.2. Oral Fluid Testing Devices
            12.2.3. Consumables
                     12.2.3.1. Fluid Collection Devices
                     12.2.3.2. Others 
     12.3. Market Value Share Analysis, by Sample Type 
            12.3.1. Saliva
            12.3.2. Breath
            12.3.3. Urine
            12.3.4. Blood
            12.3.5. Hair & Sweat
     12.4. Market Value Share Analysis, by Testing Type 
            12.4.1. Pain Management 
            12.4.2. Criminal Justice Testing 
            12.4.3. Workplace Screening
     12.5. Market Value Share Analysis, by End-user 
            12.5.1. Hospitals 
            12.5.2. Diagnostics Laboratories
            12.5.3. On-the-Spot Testing
            12.5.4. Forensic Laboratories
     12.6. Market Value Share Analysis, by Country/Sub-region
            12.6.1. Japan
            12.6.2. China
            12.6.3. India
            12.6.4. Australia & New Zealand
            12.6.5. Rest of Asia Pacific
     12.7. Market Size (US$ Mn) Forecast
            12.7.1. By Product Type
            12.7.2. By Sample Type
            12.7.3. By Testing Type
            12.7.4. By End-user
            12.7.5. By Country/Sub-region
     12.8. Market Attractiveness Analysis 
            12.8.1. By Product Type
            12.8.2. By Sample Type
            12.8.3. By Testing Type
            12.8.4. By End-user

13. Latin America Drugs of Abuse Testing Market Analysis and Forecast
     13.1. Market Overview
            13.1.1. Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016–2026
            13.1.2. Testing Market Attractiveness Analysis, by Country/Sub-region
     13.2. Market Value Share Analysis, by Product Type 
            13.2.1. Analyzers 
                     13.2.1.1. Immunoassay Analyzers
                     13.2.1.2. Chromatographic Devices
                     13.2.1.3. Breath Analyzers
            13.2.2. Rapid Testing Devices
                     13.2.2.1. Urine Testing Devices 
                     13.2.2.2. Oral Fluid Testing Devices
            13.2.3. Consumables
                     13.2.3.1. Fluid Collection Devices
                     13.2.3.2. Others 
     13.3. Market Value Share Analysis, by Sample Type 
            13.3.1. Saliva
            13.3.2. Breath
            13.3.3. Urine
            13.3.4. Blood
            13.3.5. Hair & Sweat
     13.4. Market Value Share Analysis, by Testing Type 
            13.4.1. Pain Management 
            13.4.2. Criminal Justice Testing 
            13.4.3. Workplace Screening
     13.5. Market Value Share Analysis, by End-user 
            13.5.1. Hospitals 
            13.5.2. Diagnostics Laboratories
            13.5.3. On-the-Spot Testing
            13.5.4. Forensic Laboratories
     13.6. Market Value Share Analysis, by Country/Sub-region
            13.6.1. Mexico
            13.6.2. Brazil
            13.6.3. Rest of Latin America
     13.7. Market Size (US$ Mn) Forecast
            13.7.1. By Product Type
            13.7.2. By Sample Type
            13.7.3. By Testing Type
            13.7.4. By End-user
            13.7.5. By Country/Sub-region
     13.8. Market Attractiveness Analysis 
            13.8.1. By Product Type
            13.8.2. By Sample Type
            13.8.3. By Testing Type

14. Middle East & Africa Drugs of Abuse Testing Market Analysis and Forecast
     14.1. Market Overview
            14.1.1. Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016–2026
            14.1.2. Testing Market Attractiveness Analysis, by Country/Sub-region
     14.2. Market Value Share Analysis, by Product Type 
            14.2.1. Analyzers 
                     14.2.1.1. Immunoassay Analyzers
                     14.2.1.2. Chromatographic Devices
                     14.2.1.3. Breath Analyzers
            14.2.2. Rapid Testing Devices
                     14.2.2.1. Urine Testing Devices 
                     14.2.2.2. Oral Fluid Testing Devices
            14.2.3. Consumables
                     14.2.3.1. Fluid Collection Devices
                     14.2.3.2. Others 
     14.3. Market Value Share Analysis, by Sample Type 
            14.3.1. Saliva
            14.3.2. Breath
            14.3.3. Urine
            14.3.4. Blood
            14.3.5. Hair & Sweat
     14.4. Market Value Share Analysis, by Testing Type 
            14.4.1. Pain Management 
            14.4.2. Criminal Justice Testing 
            14.4.3. Workplace Screening
     14.5. Market Value Share Analysis, by End-user 
            14.5.1. Hospitals 
            14.5.2. Diagnostics Laboratories
            14.5.3. On-the-Spot Testing
            14.5.4. Forensic Laboratories
     14.6. Market Value Share Analysis, by Country/Sub-region
            14.6.1. GCC Countries 
            14.6.2. South Africa
            14.6.3. Rest of Middle East & Africa
     14.7. Market Size (US$ Mn) Forecast
            14.7.1. By Product Type
            14.7.2. By Sample Type
            14.7.3. By Testing Type
            14.7.4. By End-user
            14.7.5. By Country/Sub-region
     14.8. Market Attractiveness Analysis 
            14.8.1. By Product Type
            14.8.2. By Sample Type
            14.8.3. By Testing Type
            14.8.4. By End-user

15. Competition Landscape
     15.1. Market Player - Competition Matrix 
     15.2. Market Share Analysis, by Company (2017)
     15.3. Company Profiles (Details - Overview, Financials, Recent Developments, Strategy)
            15.3.1. F. Hoffmann-La Roche AG
                      15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
                      15.3.1.2. Financial Overview
                      15.3.1.3. Product Portfolio
                      15.3.1.4. SWOT Analysis
                      15.3.1.5. Strategic Overview
            15.3.2. Siemens Healthineers (Siemens AG)
                      15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
                      15.3.2.2. Financial Overview
                      15.3.2.3. Product Portfolio
                      15.3.2.4. SWOT Analysis
                      15.3.2.5. Strategic Overview
            15.3.3. Thermo Fisher Scientific, Inc.
                      15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
                      15.3.3.2. Financial Overview
                      15.3.3.3. Product Portfolio
                      15.3.3.4. SWOT Analysis
                      15.3.3.5. Strategic Overview
            15.3.4. Abbott
                      15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
                      15.3.4.2. Financial Overview
                      15.3.4.3. Product Portfolio
                      15.3.4.4. SWOT Analysis
                      15.3.4.5. Strategic Overview
            15.3.5. Shimadzu Corporation
                      15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
                      15.3.5.2. Financial Overview
                      15.3.5.3. Product Portfolio
                      15.3.5.4. SWOT Analysis 
                      15.3.5.5. Strategic Overview
            15.3.6. Laboratory Corporation of America Holdings
                      15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
                      15.3.6.2. Financial Overview
                      15.3.6.3. Product Portfolio
                      15.3.6.4. SWOT Analysis 
                      15.3.6.5. Strategic Overview
            15.3.7. Danaher 
                      15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
                      15.3.7.2. Financial Overview
                      15.3.7.3. Product Portfolio
                      15.3.7.4. SWOT Analysis
                      15.3.7.5. Strategic Overview
            15.3.8. Drägerwerk AG & Co. KGaA
                      15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
                      15.3.8.2. Financial Overview
                      15.3.8.3. Product Portfolio
                      15.3.8.4. SWOT Analysis 
                      15.3.8.5. Strategic Overview
            15.3.9. Express Diagnostics International, Inc.
                      15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
                      15.3.9.2. Financial Overview
                      15.3.9.3. Product Portfolio
                      15.3.9.4. SWOT Analysis 
                      15.3.9.5. Strategic Overview

List of Tables

Table 1: Global Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Product Type, 2016–2026
Table 2: Global Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Sample Type, 2016–2026
Table 3: Global Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Testing Type, 2016–2026
Table 4: Global Drug of Abuse Testing Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 5: Global Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Region, 2016–2026
Table 6: North America Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Product Type, 2016–2026
Table 7: North America Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Sample Type, 2016–2026
Table 8: North America Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Testing Type, 2016–2026
Table 9: North America Drug of Abuse Testing Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 10: North America Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Country, 2016–2026
Table 11: Europe Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Product Type, 2016–2026
Table 12: Europe Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Sample Type, 2016–2026
Table 13: Europe Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Testing Type, 2016–2026
Table 14: Europe Drug of Abuse Testing Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 15: Europe Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 16: Asia Pacific Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Product Type, 2016–2026 
Table 17: Asia Pacific Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Sample Type, 2016–2026
Table 18: Asia Pacific Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Testing Type, 2016–2026
Table 19: Asia Pacific Drug of Abuse Testing Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 20: Asia Pacific Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 21: Latin America Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Product Type, 2016–2026
Table 22: Latin America Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Sample Type, 2016–2026
Table 23: Latin America Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Testing Type, 2016–2026
Table 24: Latin America Drug of Abuse Testing Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 25: Latin America Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 26: Middle East & Africa Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Product Type, 2016–2026 
Table 27: Middle East & Africa Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Sample Type, 2016–2026
Table 28: Middle East & Africa Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Testing Type, 2016–2026
Table 29: Middle East & Africa Drug of Abuse Testing Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 30: Middle East & Africa Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026

List of Figures

Figure 1: Global Drug of Abuse Testing Market Size (US$ Mn) Forecast, 2016–2024
Figure 2: Global Drug of Abuse Testing Market Value Share, by Product Type (2017)
Figure 3: Global Drug of Abuse Testing Market Value Share, by Sample Type (2017)
Figure 4: Global Drug of Abuse Testing Market Value Share, by Testing Type (2017)
Figure 5: Global Drug of Abuse Testing Market Value Share, by End-user (2017)
Figure 6: Global Drug of Abuse Testing Market Value Share, by Region (2017)
Figure 7: Global Drug of Abuse Testing Market Value Share Analysis, by Product Type, 2018 and 2026
Figure 8: Global Drug of Abuse Testing Market Attractiveness Analysis, by Product Type, 2018–2026
Figure 9: Global Drugs of Abuse Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Analyzers, 2016–2026 
Figure 10: Global Drugs of Abuse Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Rapid Testing Devices, 2016–2026
Figure 11: Global Drugs of Abuse Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Consumables, 2016–2026
Figure 12: Global Drugs of Abuse Testing Market Value Share Analysis, by Sample Type, 2018 and 2026
Figure 13: Global Drugs of Abuse Testing Market Attractiveness Analysis, by Sample Type, 2018-2026
Figure 14: Global Drugs of Abuse Testing Sample Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Saliva 2016–2026
Figure 15: Global Drugs of Abuse Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Breath, 2016–2026
Figure 16: Global Drugs of Abuse Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Urine, 2016–2026
Figure 17: Global Drugs of Abuse Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Blood, 2016–2026
Figure 18: Global Drugs of Abuse Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hair & Sweat 2016–2026
Figure 19: Global Drugs of Abuse Testing Market Value Share Analysis, by Testing Type, 2018 and 2026
Figure 20: Global Drugs of Abuse Testing Market Attractiveness Analysis, by Testing Type, 2018-2026
Figure 21: Global Drugs of Abuse Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Pain Management Testing, 2016–2026
Figure 22: Global Drugs of Abuse Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Criminal Justice Testing, 2016–2026
Figure 23: Global Drugs of Abuse Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Workplace Screening, 2016–2026
Figure 24: Global Drugs of Abuse Testing Market Value Share Analysis, by End Users, 2018 and 2026
Figure 25: Global Drugs of Abuse Testing Market Attractiveness Analysis, by End Users, 2018-2026
Figure 26: Global Drugs of Abuse Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2016–2026
Figure 27: Global Drugs of Abuse Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diagnostic Laboratories, 2016–2026
Figure 28: Global Drugs of Abuse Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by On-the-spot Testing, 2016–2026
Figure 29: Global Drugs of Abuse Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Forensic Laboratories, 2016–2026
Figure 30: Global Drugs of Abuse Testing Market Value Share Analysis, by Region, 2018 and 2026
Figure 31: Global Drugs of Abuse Testing Market Attractiveness Analysis, by Region, 2018-2026 
Figure 32: North America Drug of Abuse Testing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016–2026
Figure 33: North America Drug of Abuse Testing Market Attractiveness Analysis, by Country, 2018–2026
Figure 34: North America Drug of Abuse Testing Market Value Share Analysis, by Product Type, 2018 and 2026
Figure 35: North America Drug of Abuse Testing Market Value Share Analysis, by Sample Type, 2018 and 2026
Figure 36: North America Drug of abuse testing Market Value Share Analysis, by Testing Type, 2018 and 2026
Figure 37: North America Drug of abuse testing Market Value Share Analysis, by End-user, 2018 and 2026
Figure 38: North America Drug of Abuse Testing Market Value Share Analysis, by Country, 2018 and 2026
Figure 39: North America Drug of Abuse Testing Market Attractiveness Analysis, by Product Type, 2018–2026
Figure 40: North America Drug of Abuse Testing Market Attractiveness Analysis, by Sample Type, 2018–2026
Figure 41: North America Drug of Abuse Testing Market Attractiveness Analysis, by Testing Type, 2018–2026
Figure 42: North America Drug of Abuse Testing Market Attractiveness Analysis, by End-user, 2018–2026
Figure 43: Europe Drug of Abuse Testing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016–2026
Figure 44: Europe Drug of Abuse Testing Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
Figure 45: Europe Drug of Abuse Testing Market Value Share Analysis, by Product Type, 2018 and 2026
Figure 46: Europe Drug of Abuse Testing Market Value Share Analysis, by Sample Type, 2018 and 2026
Figure 47: Europe Drug of abuse testing Market Value Share Analysis, by Testing Type, 2018 and 2026
Figure 48: Europe Drug of abuse testing Market Value Share Analysis, by End-user, 2018 and 2026
Figure 49: Europe Drug of Abuse Testing Market Value Share Analysis, by Country/Sub-region, 2018 and 2026
Figure 50: Europe Drug of Abuse Testing Market Attractiveness Analysis, by Product Type, 2018–2026
Figure 51: Europe Drug of Abuse Testing Market Attractiveness Analysis, by Sample Type, 2018–2026
Figure 52: Europe Drug of Abuse Testing Market Attractiveness Analysis, by Testing Type, 2018–2026
Figure 53: Europe Drug of Abuse Testing Market Attractiveness Analysis, by End-user, 2018–2026
Figure 54: Asia Pacific Drug of Abuse Testing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016–2026
Figure 55: Asia Pacific Drug of Abuse Testing Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
Figure 56: Asia Pacific Drug of Abuse Testing Market Value Share Analysis, by Product Type, 2018 and 2026
Figure 57: Asia Pacific Drug of Abuse Testing Market Value Share Analysis, by Sample Type, 2018 and 2026
Figure 58: Asia Pacific Drug of abuse testing Market Value Share Analysis, by Testing Type, 2018 and 2026
Figure 59: Asia Pacific Drug of abuse testing Market Value Share Analysis, by End-user, 2018 and 2026
Figure 60: Asia Pacific Drug of Abuse Testing Market Value Share Analysis, by Country/Sub-region, 2018 and 2026
Figure 61: Asia Pacific Drug of Abuse Testing Market Attractiveness Analysis, by Product Type, 2018–2026
Figure 62: Asia Pacific Drug of Abuse Testing Market Attractiveness Analysis, by Sample Type, 2018–2026
Figure 63: Asia Pacific Drug of Abuse Testing Market Attractiveness Analysis, by Testing Type, 2018–2026
Figure 64: Asia Pacific Drug of Abuse Testing Market Attractiveness Analysis, by End-user, 2018–2026
Figure 65: Latin America Drug of Abuse Testing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016–2026
Figure 66: Latin America Drug of Abuse Testing Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
Figure 67: Latin America Drug of Abuse Testing Market Value Share Analysis, by Product Type, 2018 and 2026
Figure 68: Latin America Drug of Abuse Testing Market Value Share Analysis, by Sample Type, 2018 and 2026
Figure 69: Latin America Drug of abuse testing Market Value Share Analysis, by Testing Type, 2018 and 2026
Figure 70: Latin America Drug of abuse testing Market Value Share Analysis, by End-user, 2018 and 2026
Figure 71: Latin America Drug of Abuse Testing Market Value Share Analysis, by Country/Sub-region, 2018 and 2026
Figure 72: Latin America Drug of Abuse Testing Market Attractiveness Analysis, by Product Type, 2018–2026
Figure 73: Latin America Drug of Abuse Testing Market Attractiveness Analysis, by Sample Type, 2018–2026
Figure 74: Latin America Drug of Abuse Testing Market Attractiveness Analysis, by Testing Type, 2018–2026
Figure 75: Latin America Drug of Abuse Testing Market Attractiveness Analysis, by End-user, 2018–2026
Figure 76: Middle East & Africa Drug of Abuse Testing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016–2026
Figure 77: Middle East & Africa Drug of Abuse Testing Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
Figure 78: Middle East & Africa Drug of Abuse Testing Market Value Share Analysis, by Product Type, 2018 and 2026
Figure 79: Middle East & Africa Drug of Abuse Testing Market Value Share Analysis, by Sample Type, 2018 and 2026
Figure 80: Middle East & Africa Drug of abuse testing Market Value Share Analysis, by Testing Type, 2018 and 2026
Figure 81: Middle East & Africa Drug of abuse testing Market Value Share Analysis, by End-user, 2018 and 2026
Figure 82: Middle East & Africa Drug of Abuse Testing Market Value Share Analysis, by Country/Sub-region, 2018 and 2026
Figure 83: Middle East & Africa Drug of Abuse Testing Market Attractiveness Analysis, by Product Type, 2018–2026
Figure 84: Middle East & Africa Drug of Abuse Testing Market Attractiveness Analysis, by Sample Type, 2018–2026
Figure 85: Middle East & Africa Drug of Abuse Testing Market Attractiveness Analysis, by Testing Type, 2018–2026
Figure 86: Middle East & Africa Drug of Abuse Testing Market Attractiveness Analysis, by End-user, 2018–2026
Figure 87: Global Drugs of Abuse Testing Market, Company Share Analysis, 2018–2026

.